303 related articles for article (PubMed ID: 33882283)
1. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
2. Roche DAT immunoassay: sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid.
Crooks CR; Brown S
J Anal Toxicol; 2010 Mar; 34(2):103-9. PubMed ID: 20223103
[TBL] [Abstract][Full Text] [Related]
3. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
[TBL] [Abstract][Full Text] [Related]
4. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing.
Concheiro M; de Castro A; Quintela O; Cruz A; López-Rivadulla M
Forensic Sci Int; 2007 Aug; 170(2-3):156-62. PubMed ID: 17658709
[TBL] [Abstract][Full Text] [Related]
5. Detection of Delta9-tetrahydrocannabinol and amphetamine-type stimulants in oral fluid using the Rapid Stat point-of-collection drug-testing device.
Röhrich J; Zörntlein S; Becker J; Urban R
J Anal Toxicol; 2010 Apr; 34(3):155-61. PubMed ID: 20406540
[TBL] [Abstract][Full Text] [Related]
6. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
[TBL] [Abstract][Full Text] [Related]
7. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Forensic Sci Int; 2015 Nov; 256():42-5. PubMed ID: 26295911
[TBL] [Abstract][Full Text] [Related]
8. Performance evaluation of the DrugWipe® 5/5+ on-site oral fluid screening device.
Pehrsson A; Blencowe T; Vimpari K; Impinen A; Gunnar T; Lillsunde P
Int J Legal Med; 2011 Sep; 125(5):675-83. PubMed ID: 20652713
[TBL] [Abstract][Full Text] [Related]
9. Analytical evaluation of four on-site oral fluid drug testing devices.
Vanstechelman S; Isalberti C; Van der Linden T; Pil K; Legrand SA; Verstraete AG
J Anal Toxicol; 2012 Mar; 36(2):136-40. PubMed ID: 22337784
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a single LC-MS/MS assay following SPE for simultaneous hair analysis of amphetamines, opiates, cocaine and metabolites.
Imbert L; Dulaurent S; Mercerolle M; Morichon J; Lachâtre G; Gaulier JM
Forensic Sci Int; 2014 Jan; 234():132-8. PubMed ID: 24378313
[TBL] [Abstract][Full Text] [Related]
11. Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry.
Fritch D; Blum K; Nonnemacher S; Haggerty BJ; Sullivan MP; Cone EJ
J Anal Toxicol; 2009; 33(9):569-77. PubMed ID: 20040131
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the IDS One-Step ELISA kits for the detection of illicit drugs in hair.
Pujol ML; Cirimele V; Tritsch PJ; Villain M; Kintz P
Forensic Sci Int; 2007 Aug; 170(2-3):189-92. PubMed ID: 17628371
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
[TBL] [Abstract][Full Text] [Related]
15. Field Detection of Drugs of Abuse in Oral Fluid Using the Alere™ DDS®2 Mobile Test System with Confirmation by Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS).
Krotulski AJ; Mohr ALA; Friscia M; Logan BK
J Anal Toxicol; 2018 Apr; 42(3):170-176. PubMed ID: 29301050
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous screening and quantification of 29 drugs of abuse in oral fluid by solid-phase extraction and ultraperformance LC-MS/MS.
Badawi N; Simonsen KW; Steentoft A; Bernhoft IM; Linnet K
Clin Chem; 2009 Nov; 55(11):2004-18. PubMed ID: 19797719
[TBL] [Abstract][Full Text] [Related]
17. A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.
Huestis MA
Clin Chem; 2009 Dec; 55(12):2079-81. PubMed ID: 19833833
[No Abstract] [Full Text] [Related]
18. Oral Fluid and Drug Impairment: Pairing Toxicology with Drug Recognition Expert Observations.
Truver MT; Palmquist KB; Swortwood MJ
J Anal Toxicol; 2019 Sep; 43(8):637-643. PubMed ID: 31504595
[TBL] [Abstract][Full Text] [Related]
19. On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users.
Samyn N; van Haeren C
Int J Legal Med; 2000; 113(3):150-4. PubMed ID: 10876986
[TBL] [Abstract][Full Text] [Related]
20. Optimization and validation of CEDIA drugs of abuse immunoassay tests in serum on Hitachi 912.
Kirschbaum KM; Musshoff F; Schmithausen R; Stockhausen S; Madea B
Forensic Sci Int; 2011 Oct; 212(1-3):252-5. PubMed ID: 21775079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]